Tectonic Therapeutic Inc.

16.84
-0.87 (-4.91%)
At close: Apr 01, 2025, 3:59 PM
17.00
0.98%
After-hours: Apr 01, 2025, 07:56 PM EDT
-4.91%
Bid 15.64
Market Cap 314.19M
Revenue (ttm) n/a
Net Income (ttm) -129.8M
EPS (ttm) -6.49
PE Ratio (ttm) -2.59
Forward PE -4.98
Analyst Buy
Ask 18.5
Volume 179,090
Avg. Volume (20D) 354,726
Open 17.77
Previous Close 17.71
Day's Range 16.51 - 18.46
52-Week Range 1.40 - 61.07
Beta 1.29

About TECX

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure...

Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 51
Stock Exchange NASDAQ
Ticker Symbol TECX
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for TECX stock is "Buy." The 12-month stock price forecast is $72.5, which is an increase of 330.65% from the latest price.

Stock Forecasts
2 months ago
+113.22%
Tectonic Therapeutic shares are trading higher aft... Unlock content with Pro Subscription